Exela Pharma Sciences LLC
At a glance
Employees500+
In business sinceNot reported
HeadquartersLenoir, NC
US patents21
SAM.gov UEIM6CZR21V9HX9
CAGE code7A4M2
Incorporated inDE
- fast-growing
- integrated specialty pharmaceutical
- sterile injectable products
- contract development
- manufacturing organization
- CDMO
- patient experience
- ease drug shortages
- Units
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of GoodsMinority Owned Business
Self-certified by the company in its SAM.gov registration
Patents
21 US patents granted 2016–2025, 17 of them in the five years to SEP 2025.
Pharmaceuticals 21
- Stable, highly pure L-cysteine compositions for injection and methods of useUS 12,186,338 · granted JAN 7, 2025
- Stable, highly pure L-cysteine compositions for injection and methods of useUS 12,171,781 · granted DEC 24, 2024
- Stable, highly pure L-cysteine compositions for injection and methods of useUS 11,969,439 · granted APR 30, 2024
- Stable, highly pure L-cysteine compositions for injection and methods of useUS 11,826,383 · granted NOV 28, 2023
- Ganciclovir compositions and related methodsUS 11,723,978 · granted AUG 15, 2023
Newest 5 shown · Granted to Exela Pharma Sciences, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Exela Pharma Sciences LLC | Lenoir | NC | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.